ADVERTISEMENT

From the Desk of the CEO

Community pharmacists are rewriting the rules of practice
James Keagy
/ Categories: CEO Blog

Community pharmacists are rewriting the rules of practice

Two independent pharmacists show how autonomy, transparency, and clinical care can restore joy—and sustainability—to community pharmacy

Over the past 3 years, I’ve spoken with many community pharmacists who are deeply dissatisfied with their work. The reasons are well known and don’t need repeating. What deserves more attention is what is working—and how those examples can help move our profession forward.

Recently, at the Pennsylvania Pharmacists Association meeting in Harrisburg, I met two community pharmacists who are experiencing something rarely discussed: professional fulfillment. Brandon Antinopoulos, PharmD, of Forward Rx Pharmacy and Kyle McCormick, PharmD, of Blueberry Pharmacy are building practices that look very different from the status quo—and their experiences offer a powerful lesson for the profession.

Starting with a simple goal: Serve patients without interference

Both pharmacists began with the same core motivation: a love for their communities and the patients they serve. They wanted to practice pharmacy without interference that distracted from patient care.

To do that, each adopted a cost-plus pharmacy model. They calculated the true cost of providing prescription medications, added a reasonable and transparent fee to ensure sustainability, and made that pricing public so patients could clearly understand the value being delivered. Insurance is accepted only when payers agree to those cost-plus terms.

The result? Predictability. Transparency. And control.

Predictable revenue, early profitability, and growing demand

The outcomes of this approach have been striking. I haven’t seen two pharmacists in a long time who were as calm, confident, and satisfied in their professional lives. One told me he became profitable very quickly after opening and no longer worries about when—or whether—he will be paid.

Both practices continue to grow month after month. One has established contracts with local employers to provide clinical services, while the other has built strong referral relationships with physicians in the community.

In each case, their business models don't compete with patient care—they enable it.

Practicing at the top of their training—and why it matters

These pharmacists are doing exactly what they were trained to do. Their practices are highly clinical. They intervene daily as medication therapy experts, ensuring appropriate therapy, and better outcomes—and they are paid directly for that work.

Rather than waiting for perfect conditions or system-wide reform, they defined their clinical services, set clear fees, and educated their communities about what they offer.

A major source of their professional fulfillment is control—over clinical decisions, time, and how patient needs are met. That autonomy has made a meaningful difference for both pharmacists and patients.

Many student pharmacists struggle with the tension between patient care and administrative burden. Some ultimately look outside direct care, even though caring for patients is what drew them to pharmacy in the first place.

What these two pharmacists demonstrate is that a full, rewarding career in direct patient care is already happening in communities across the country.

The path forward is already being built

Congratulations to Antinopoulos and McCormick for leading the way. Their work shows that community pharmacy does not need to abandon patient care to survive—it needs our collective encouragement to rethink how care is delivered and valued.

For every pharmacist. For all of pharmacy.

Previous Article APhA: Adding value to member’s lives
Next Article Lessons from Coach Lou Holtz
Print
4649
Please login or register to post comments.

Featured Post

Posted: Mar 10, 2026

Lessons from Coach Lou Holtz

APhA CEO Michael Hogue reflects on the wisdom of legendary football coach Lou Holt, while encouraging pharmacy professionals to consider how the coach’s words may impact their role in the profession.

All Posts

Posted: May 11, 2026

One life lost is one too many—Pharmacists must be part of the solution

As the nation confronts the ongoing substance use disorder and overdose crisis, APhA is continuing to advocate for pharmacists to be recognized as essential members of the care team. In this blog, CEO Michael Hogue reflects on the release of the new National Drug Control Strategy, the lives impacted by addiction, and the critical role pharmacists play in prevention, treatment, recovery, and connecting patients to care.

Posted: Apr 23, 2026

APhA’s member-driven policy response on vertical integration

As policymakers debate major changes to the pharmaceutical supply chain, APhA is taking a deliberate, member driven approach to one of pharmacy’s most complex issues: vertical integration. In this blog, CEO Michael Hogue shares how our members, the House of Delegates, and Board of Trustees are shaping a thoughtful, transparent policy response.

Posted: Mar 10, 2026

Lessons from Coach Lou Holtz

APhA CEO Michael Hogue reflects on the wisdom of legendary football coach Lou Holt, while encouraging pharmacy professionals to consider how the coach’s words may impact their role in the profession.

Posted: Feb 26, 2026

Community pharmacists are rewriting the rules of practice

In his latest blog, CEO Michael Hogue highlights two pharmacists redefining what community practice can be. Their innovative models show how autonomy and clinical care can thrive together.

Posted: Dec 16, 2025

APhA: Adding value to member’s lives

Key accomplishments on behalf of APhA members

In this blog, APhA CEO Michael Hogue reflects on a year of progress and resilience, highlighting how APhA delivered meaningful value to members amid a challenging health care landscape.

Voices of APhA

Perspectives & Stories from Our Staff

Posted: Jun 3, 2026

The bill formerly known as ECAPS

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an inside look at recent congressional activity surrounding H.R. 3164—the “Main Street Pharmacy Access Act,” formerly known as ECAPS. He breaks down what this progress means for pharmacists, patients, and the broader healthcare system, and why this moment represents an important step toward recognizing pharmacists as essential Part B providers.

Posted: Apr 30, 2026

Redefining Possible: A personal reflection on passion, purpose, and joy

Magaly Rodriguez de Bittner, PharmD, MS, FAPhA, FNAP, FFIP, President, APhA

Magaly Rodriguez de Bittner, PharmD, MS, FAPhA, FNAP, FFIP—in her first blog as APhA President—reflects on the values that continue to shape the future of pharmacy: passion, purpose, and joy.

Posted: Aug 21, 2025

A peek behind reconciliation

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Douglas Huynh offers a behind-the-scenes look at how lobbying works in practice—cutting through spin, navigating political realities, and seizing legislative opportunities. Through the story of the ECAPS Act and its attempt to ride along in a reconciliation package, he shows how politics often trumps policy, even when everything seems lined up for success.

Guest Spotlights

Thought Leadership & Contributions from Industry Experts

Posted: Jun 10, 2026

Offer vaccines just as strongly as last year

Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, Managing Editor, IZ Express, Immunize.org

In a new guest blog from APhA, Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, encourages pharmacists to continue giving strong vaccine recommendations and reminds the profession that vaccines remain one of the safest and most effective tools to prevent serious illness and death.

Posted: Jun 8, 2026

The Importance of Motivational Interviewing and Patient Connection

Bruce A. Berger, PhD, Professor Emeritus, Auburn University Harrison College of Pharmacy

Fifteen years ago, William Villaume and I developed our sense making approach to motivational interviewing (MI) based on Brenda Dervin's sense making theory.

Posted: Apr 10, 2026

APhA: Still all in

Guest blog from Alex Varkey, PharmD, MS, FAPhA

After 25 years as a member of APhA, and more than 20 years of active service in a variety of leadership roles,—Alex Varkey is sharing a personal reflection you won’t want to miss.

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT